A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00444613 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

373

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: E0302 (mecobalamin)
DRUG: E0302 (mecobalamin)
DRUG: Placebo

Sponsor

Eisai Co., Ltd.